Whitehawk Therapeutics, Inc. (WHWK)
4.70
-0.40
(-7.84%)
USD |
NASDAQ |
May 15, 16:00
4.68
-0.02
(-0.43%)
After-Hours: 20:00
Whitehawk Therapeutics EPS Diluted (Quarterly) : -0.3206 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.0487 |
| Replimune Group, Inc. | -0.7694 |
| Lantern Pharma, Inc. | -0.2958 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.19M |
| Total Expenses (Quarterly) | 22.19M |
| Enterprise Value | 109.38M |
| Earnings Yield | -35.63% |
| Normalized Earnings Yield | -35.63 |